Re: Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study
During the 23 years of my psychiatric practice I have made the observation on numerous occasions that as soon as a woman has her first antenatal visit, the first precaution is to slash the “psychotropic medicines”, including the mood stabilizers. Although this happens with a good intention of protecting the fetus, yet most of the time it is without the realization that the risk of untreated bipolar illness could prove even more dangerous for the fetus and mother than the treatment itself.
Is the combined risks of having bipolar illness and being exposed to a mood stabilizer bigger than the relapse or risky behavior that a patient may develop if we withdraw the mood stabilizer?
This study adds to the fact that there are othersrisks that have to be kept in mind when we decide about the individualized care, assessment of risks and communication of those risks to our patients.